By Karen Roman
Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life science company, reported it has opened a new cutting-edge laboratory space in Cambridge, U.K.
This new facility sits within a space of 150 acres and 2 million square feet of advanced technology and laboratory buildings and it houses some of the world’s top technology and life science companies, the company stated.
At this new laboratory, Conduit will focus on expanding its intellectual property portfolio and it will become the company’s workstream management platform, it stated.
“Our new laboratory serves as a dynamic base for Conduit’s breakthrough endeavours, providing an optimal environment to progress and expand upon our existing asset portfolio while also facilitating a generation of new intellectual property,” said Dr. David Tapolczay, Conduit’s CEO.
Editor@Executives-edge.com
